Overview

Xenon and Cooling Therapy in Babies at High Risk of Brain Injury Following Poor Condition at Birth

Status:
Active, not recruiting

Trial end date:
2021-09-30

Target enrollment:

Participant gender:

Summary

This study examines the effect of inhaled xenon gas in the treatment of newborn infants with hypoxic-ischemic encephalopathy (HIE) in combination with cooling, which is the standard treatment for this condition. The hypothesis is that the xenon + cooling combination will produce better neuroprotection than the standard treatment of cooling alone.

Phase:

Phase 2

Details

Lead Sponsor:

University Hospitals Bristol and Weston NHS Foundation Trust
University Hospitals Bristol NHS Foundation Trust

Collaborator:

University of Bristol

Treatments:

Xenon